A prospectively maintained database at an academic medical center was used to identify individuals with SDHx PVs. The research team abstracted demographics, clinical, genomic, and variant information ...
Attruby is the first near-complete (≥90%) stabilizer of Transthyretin (TTR) approved in the U.S. for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback